APH — Amphenol Corporation
Fundamentals Score: 66/100 (Good Fundamentals) · Technology
Amphenol Corporation, alongside its numerous subsidiaries, operates globally as a prominent designer, manufacturer, and distributor of electrical, electronic, and fiber optic connectors. Its market reach extends across the United States, China, and various international territories.
Score Breakdown
Live Market DataPrice updated: 1d ago
AI Deep-Dive Analysis
Analysis as of 2026-08-27 - price/technical figures below reflect that date, not live market dataAs of 2026-08-27, Amphenol trades at $161.38 with a ~$199B market cap following a record Q2 2026 (reported revenue +55% y/y, 30% organic growth). The analyst consensus is Buy, but the stock is priced above its own historical multiples, so the setup is strong fundamentals at a rich valuation.
The July 29 Q2 beat — adjusted EPS $1.35 vs. ~$1.18 expected and Communication Solutions revenue up ~85% y/y — triggered a wave of price-target raises to $197-$215. As of 2026-08-27, the tape has cooled, with RSI at 50.8 and price roughly flat, but sell-side tone and forward guidance remain decisively positive.
Revenue has moved from $3.20B in Sep-2023 to $8.76B in Jun-2026, with Q2 2026 growing 55% reported / 30% organic y/y. Operating margin expanded from roughly 21% in 2024 to 29.5% in Q2 2026. Q1 2026 net margin dipped to 12.4%, likely acquisition/integration noise, then snapped back to 20.2% in Q2. H1 2026 free cash flow was $2.03B vs. $1.70B in H1 2025. This is an accelerating trend, not a one-off blip.
Expensive by APH's own history. TTM P/E is 38.4x vs. the 5-year average of 32.1x; P/S is 6.86x vs. 5.15x; P/B is 12.8x. Forward P/E on 2026E EPS of $5.263 is about 30.7x, which is less intimidating but still a premium. The PEG of 0.64 only looks reasonable if the current ~57% EPS growth persists; valuation leaves little room for an execution slip.
At $161.38, the market is paying roughly 31x forward earnings for a company expected to grow EPS ~57% this year. That is not pricing in a collapse; it is pricing in continued AI datacom strength and successful M&A integration. If Q3 comes in at the $9.3-9.4B revenue / $1.40-1.42 EPS guide, estimates rise and the multiple may look reasonable. If hyperscaler AI capex inflects down, the current multiple leaves meaningful downside.
As of 2026-08-27, RSI stood at 50.8, price was 1.6% below the 20-day SMA, 0.1% above the 50-day SMA, and 11.3% above the 200-day SMA. The longer-term uptrend is intact, but short-term momentum is flat/rangebound. Entry timing is not an oversold setup; better risk/reward is on a pullback toward the $155 area or a decisive close above $165.
- AI infrastructure capex cycle: hyperscaler data center builds are the primary demand driver, with IT datacom revenue up ~85% y/y.
- Interest rates and multiple compression: a 38x trailing P/E makes APH sensitive to higher-for-longer rates.
- Aerospace and defense budgets: defense interconnect demand provides a stable offset to commercial cyclicality.
- Geopolitics and China supply chain: tariffs and export controls could raise costs or disrupt end-market exposure.
- M&A integration and balance-sheet capacity: debt/equity of 1.21x and long-term debt of $17.2B make integration execution a swing factor.
- Q3 2026 earnings, expected late October 2026, with guidance already at $9.3-$9.4B revenue and EPS of $1.40-$1.42.
- Continued AI/datacom order momentum and next-gen server platform ramps.
- CommScope CCS and Wilder Technologies integration synergies and margin accretion.
- Capital returns: ~$1.6B in buybacks YTD plus quarterly dividend growth.
- AI capex normalization or pull-forward exhaustion in hyperscaler spending would directly hit the highest-growth segment.
- Valuation de-rating: 38.4x TTM and 30.7x forward earnings leave limited cushion if growth slows.
- Integration and leverage risk after large acquisitions, with long-term debt at $17.2B.
- Customer concentration among large IT/datacom buyers and geopolitical/China supply-chain exposure.
Amphenol is a best-in-class connectivity franchise with accelerating revenue, expanding margins, and strong cash generation, squarely positioned in the AI infrastructure buildout. But at $161.38 the market already knows this, so the risk/reward is constructive rather than compelling; I would be a buyer closer to the 50-day SMA or on an AI-capex scare, not a chaser at the high end of its valuation range. This is analysis, not personalized financial advice.
Applied a justified forward P/E of ~36x to 2026E EPS of $5.263, a premium to APH's 5-year average of 32.1x driven by ~57% expected EPS growth and a PEG of 0.64. That computes to about $189.50, rounded to $190 — above the current price but below the more aggressive Street targets, reflecting quality plus rich valuation.
AI Review of the Deterministic Score
The 66/Good score is in the right ballpark. My independent read sees a slightly better operating picture — operating margin near 30%, Q2 net margin over 20%, ROE ~32%, and strong free cash flow — and the Q1 2026 margin dip appears to be one-off noise rather than deterioration. I would nudge the fundamental score into the low 70s, but the Good band still stands; no large qualitative adjustment is warranted by the data or the research brief.
AI-generated analysis for informational purposes only, not financial advice.